Literature DB >> 11204810

The extent of duodenogastric reflux in gastro-oesophageal reflux disease.

R E Marshall1, A Anggiansah, W A Owen, D K Manifold, W J Owen.   

Abstract

BACKGROUND: It is known that duodenogastro-oesophageal reflux (DGOR) increases with worsening gastro-oesophageal reflux disease (GORD). It is unclear whether this is accompanied by increasing duodenogastric reflux (DGR).
OBJECTIVE: To investigate the extent of DGR in a control group and 66 patients with GORD, using the technique of ambulatory gastric bilirubin monitoring.
METHODS: Sixty-six patients with reflux symptoms (30 grade 0 or 1 oesophagitis (group 1), 16 grade 2 or 3 oesophagitis (group 2), 20 Barrett's oesophagus (group 3)) and 17 healthy controls were studied. All underwent oesophageal manometry followed by 24-h ambulatory oesophageal and gastric pH monitoring and gastric bilirubin monitoring.
RESULTS: Median per cent total oesophageal acid exposure (pH < 4) was significantly less in the control group (0.6%) than in group 1 (2.8%, P< 0.05) and groups 2 and 3 (7.5% and 7.8% respectively, P< 0.001). There was no significant difference between any group in median per cent total time gastric pH was greater than 4. There was no significant difference in median per cent total gastric bilirubin exposure (absorbance > 0.14) between any group. However, in each group gastric bilirubin exposure was greater in the supine position than the upright position, being significantly greater in the control group (P< 0.05) and group 1 (P < 0.001).
CONCLUSIONS: Gastric bilirubin exposure is similar across the spectrum of GORD severity. It is greater in the supine than in the upright position.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11204810     DOI: 10.1097/00042737-200101000-00002

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  8 in total

1.  Assessment of duodenogastric reflux by combined continuous intragastric pH and bilirubin monitoring.

Authors:  Fei Dai; Jun Gong; Ru Zhang; Jin-Yan Luo; You-Ling Zhu; Xue-Qin Wang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

2.  Rabeprazole combined with hydrotalcite is effective for patients with bile reflux gastritis after cholecystectomy.

Authors:  Huimin Chen; Xiaobo Li; Zhizheng Ge; Yunjie Gao; Xiaoyu Chen; Yun Cui
Journal:  Can J Gastroenterol       Date:  2010-03       Impact factor: 3.522

Review 3.  Medical conditions and erosive tooth wear.

Authors:  R Moazzez; R Austin
Journal:  Br Dent J       Date:  2018-03-02       Impact factor: 1.626

4.  [Antireflux therapy--more than acid reduction?].

Authors:  T Frieling
Journal:  Internist (Berl)       Date:  2004-12       Impact factor: 0.743

5.  Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors.

Authors:  G H Koek; D Sifrim; T Lerut; J Janssens; J Tack
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

6.  Gastric bilirubin monitoring to assess duodenogastric reflux.

Authors:  Martin Fein; Stephan M Freys; Marco Sailer; Jörn Maroske; Harald Tigges; Karl-Hermann Fuchs
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

7.  Duodeno-gastric-esophageal reflux--what is pathologic? Comparison of patients with Barrett's esophagus and age-matched volunteers.

Authors:  Eva Wolfgarten; Benito Pütz; Arnulf H Hölscher; Elfriede Bollschweiler
Journal:  J Gastrointest Surg       Date:  2007-04       Impact factor: 3.452

8.  24-Hour Measurement of Gastric pH in Rural South Africa.

Authors:  Alastair M Sammon; Eugene J Ndebia; Ekambaram Umapathy; Jehu E Iputo
Journal:  Gastroenterol Res Pract       Date:  2015-03-12       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.